← Back to Search

Exercise Therapy for Cancer and COVID-19 Recovery

Phase 1
Waitlist Available
Led By Jessica Scott, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18
If a female of child-bearing potential, must not be pregnant or planning to become pregnant during the study.
Must not have
Currently receiving home oxygen after discharge
Receiving non-hormonal anticancer therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will evaluate the safety of an aerobic exercise therapy program for cancer patients recovering from COVID-19. The therapy being used is a walking program that will be adjusted to match participant fitness levels.

Who is the study for?
This trial is for adults over 18 who have had cancer, are recovering from COVID-19, and do less than 90 minutes of exercise a week. They must have space for a treadmill at home and be cleared to exercise. Women able to have children must not be pregnant or planning pregnancy during the study.
What is being tested?
The trial tests a 30-week walking program tailored to fitness levels in cancer patients recovering from COVID-19. It aims to see if this aerobic exercise therapy is safe and causes few or mild side effects.
What are the potential side effects?
Since the intervention involves aerobic exercise, potential side effects may include muscle soreness, fatigue, joint pain, or shortness of breath. However, these are expected to be mild as the program matches participant fitness levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am not pregnant nor planning to become pregnant during the study.
Select...
I was hospitalized due to Covid-19.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am using oxygen at home after being discharged from the hospital.
Select...
I am currently on a cancer treatment that does not involve hormone therapy.
Select...
My cancer has spread to distant parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Frequency of serious adverse events during study-related assessments

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants who were hospitalized for COVID-19Experimental Treatment1 Intervention
Participants will be post-cancer treatment patients who were hospitalized for COVID-19.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,969 Previous Clinical Trials
597,432 Total Patients Enrolled
Jessica Scott, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
6 Previous Clinical Trials
837 Total Patients Enrolled

Media Library

Aerobic Exercise Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04824443 — Phase 1
Coronavirus Infection Research Study Groups: Participants who were hospitalized for COVID-19
Coronavirus Infection Clinical Trial 2023: Aerobic Exercise Therapy Highlights & Side Effects. Trial Name: NCT04824443 — Phase 1
Aerobic Exercise Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04824443 — Phase 1
~0 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top